5-Hydroxytryptamine (5-HT) and the initiation of migraine: new perspectives

No abstract is available for this paper.

• Publication year

  1994

• Venue

  Naunyn-Schmiedeberg's Archives of Pharmacology

• Publication date

  1994-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/BF00175026PMID 7824037
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Further studies of the putative serotonin agonist, m-chlorophenylpiperazine: Evidence for a serotonin receptor mediated mechanism of action in humans

  2004cited by this paper
• Pharmacokinetics of methysergide and its metabolite methylergometrine in man

  2004cited by this paper
• 5-Hydroxytryptamine and the pathophysiology of migraine

  2004cited by this paper
• [Serotonin and migraine].

  2001cited by this paper
• Cloning and functional characterization of the human 5‐HT2B serotonin receptor

  1994cited by this paper
• Nitric oxide‐dependent release of vasodilator quantities of calcitonin gene‐related peptide from capsaicin‐sensitive nerves in rabbit skin

  1994cited by this paper
• Is migraine prophylactic activity caused by 5-HT2B or 5-HT2C receptor blockade?

  1994cited by this paper
• Nitric oxide supersensitivity: a possible molecular mechanism of migraine pain.

  1993cited by this paper
• A proposed new nomenclature for 5-HT receptors.

  1993cited by this paper
• Participation of nitric oxide in the mustard oil-induced neurogenic inflammation of the rat paw skin.

  1993cited by this paper
• Headache and Cortisol Responses to M-Chlorophenylpiperazine are Highly Correlated

  1993cited by this paper
• Pharmacological characteristics of the newly cloned rat 5-hydroxytryptamine2F receptor.

  1993cited by this paper
• On Serotonin and Migraine: A Clinical and Pharmacological Review

  1993cited by this paper
• Endothelium-dependent relaxation of porcine pulmonary arteries via 5-HT1C-like receptors

  1993cited by this paper
• Endothelial relaxing 5-hydroxytryptamine receptors in the rat jugular vein: similarity with the 5-hydroxytryptamine1C receptor.

  1993cited by this paper
• The effect of endogenous nitric oxide on neurogenic plasma exudation in guinea-pig airways.

  1992cited by this paper
• Interpreting Vessel Diameter Changes in Vascular Headaches

  1992cited by this paper
• Calcitonin gene-related peptide mediates nitroglycerin and sodium nitroprusside-induced vasodilation in feline cerebral arterioles.

  1992cited by this paper
• Neurogenic versus vascular mechanisms of sumatriptan and ergot alkaloids in migraine.

  1992cited by this paper
• Cloning and functional characterization of the rat stomach fundus serotonin receptor.

  1992cited by this paper
• Headache Responses Following m‐Chlorophenylpiperazine in Bulimics and Controls

  1992cited by this paper
• Modulation of acute inflammation by endogenous nitric oxide.

  1992cited by this paper
• Molecular cloning, functional expression, and pharmacological characterization of a novel serotonin receptor (5-hydroxytryptamine2F) from rat stomach fundus.

  1992cited by this paper
• More on mCPP and Migraine

  1992cited by this paper
• Further Definition of the 5-HT Receptor Mediating Contraction of Rat Stomach Fundus: Relation to 5-HT 1D Recognition Sites

  1991cited by this paper
• m-Chlorophenylpiperazine as a probe of serotonin function.

  1991cited by this paper
• Characterization of the 5‐HT receptor mediating endothelium‐dependent relaxation in porcine vena cava

  1991cited by this paper
• Metergoline blocks the behavioral and neuroendocrine effects of orally administered m-chlorophenylpiperazine in patients with obsessive-compulsive disorder.

  1991cited by this paper
• Serotonin: Molecular Biology, Receptors and Functional Effects

  1991cited by this paper
• Effects of ritanserin on the behavioral, neuroendocrine, and cardiovascular responses to meta-chlorophenylpiperazine in healthy human subjects.

  1991cited by this paper
• Hypothesis: Serotonin‐1C Receptor Activation in Migraine: An Alternative Point of View With Therapeutic Implication

  1991cited by this paper
• Serotonin and Migraine

  1990cited by this paper
• The 5‐HT1C Receptor

  1990cited by this paper
• Effects of serotonin antagonists on m-chlorophenylpiperazine-mediated responses in normal subjects.

  1990cited by this paper
• 5-HT in migraine: evidence from 5-HT receptor antagonists for a neuronal aetiology

  1990cited by this paper
• 5-Hydroxytryptamine and its putative aetiological involvement in migraine

  1989cited by this paper
• 5-HT1C receptor activation: a key step in the initiation of migraine?

  1989cited by this paper
• 5-HT(1)-like receptor agonists and the pathophysiology of migraine.

  1989cited by this paper
• Induction of migrainelike headaches by the serotonin agonist m‐chlorophenylpiperazine

  1988cited by this paper
• Functional correlates of serotonin 5-HT1 recognition sites.

  1988cited by this paper
• Differential classification of vascular smooth muscle and endothelial cell 5‐HT receptors by use of tryptamine analogues

  1987cited by this paper
• Further evidence that the serotonin receptor in the rat stomach fundus is not 5HT1A or 5HT1B.

  1986cited by this paper
• Proposals for the classification and nomenclature of functional receptors for 5-hydroxytryptamine.

  1986cited by this paper
• Characterization of 5-hydroxytryptamine receptors in rat stomach fundus.

  1985cited by this paper
• Ketanserin a Selective Serotonin Antagonist, in Relation to Platelet Aggregation and Migraine Attack Rate

  1985cited by this paper
• β-Adrenoceptor Blockade and Migraine

  1982cited by this paper
• Beta-adrenoceptor blockade and migraine.

  1982cited by this paper
• Headache provocation by continuous intravenous infusion of histamine. Clinical results and receptor mechanisms

  1980cited by this paper
• The predictable relationship between plasma levels and dose during chronic propranolol therapy

  1978cited by this paper
• SHORT‐TERM CLINICAL TRIAL of PROPRANOLOL IN RACEMIC FORM (INDERAL), D‐PROPRANOLOL and PLACEBO IN MIGRAINE

  1976cited by this paper
• To-day's Drugs

  1963cited by this paper

• Effects of warm needle acupuncture on behavioral pain threshold in a rat model of migraine

  2025cites this paper
• Triptan treatment is associated with a higher number of red wine‐induced migraine episodes: An exploratory questionnaire‐based survey

  2024cites this paper
• Provocation of attacks to discover migraine signaling mechanisms and new drug targets: early history and future perspectives - a narrative review

  2024cites this paper
• Serotonin and nociception: from nociceptive transduction at the periphery to pain modulation from the brain

  2019cites this paper
• Fragment-based approaches in GPCR-targeted drug discovery

  2018cites this paper
• Fingerprint-Based Machine Learning Approach to Identify Potent and Selective 5-HT2BR Ligands

  2018cites this paper
• Putative role of 5-HT2B receptors in migraine pathophysiology

  2017cites this paper
• The effect and safety of monoclonal antibodies to calcitonin gene-related peptide and its receptor on migraine: a systematic review and meta-analysis

  2017cites this paper
• The Role of 5-Hydroxytryptamine in the Pathophysiology of Migraine and its Relevance to the Design of Novel Treatments.

  2017cites this paper
• BF-1--a novel selective 5-HT2B receptor antagonist blocking neurogenic dural plasma protein extravasation in guinea pigs.

  2015cites this paper
• QT Prolongation, Torsade de Pointes, Myocardial Ischemia From Coronary Vasospasm, and Headache Medications. Part 1: Review of Serotonergic Cardiac Adverse Events With a Triptan Case

  2013cites this paper
• Drugs Affecting 5-HT Systems

  2013cites this paper
• Drug and Alcohol Dependence

  2012cites this paper
• The Clinical Potential of Endothelin Receptor Antagonists in Cardiovascular Medicine

  2012cites this paper
• Psilocybin dose-dependently causes delayed, transient headaches in healthy volunteers.

  2012cites this paper
• silocybin dose-dependently causes delayed , transient headaches in healthy olunteers atthew

  2011cites this paper
• Neurogenic Vascular Responses in the Dura Mater and their Relevance for the Pathophysiology of Headaches

  2009cites this paper
• Protective compounds in animal models of trigeminal activation and neurodegeneration

  2009cites this paper
• Effect of central serotonin depletion on 5-HT receptor-mediated vasomotor responses in the middle meningeal artery of anaesthetized rats.

  2009cites this paper
• Headache Currents

  2009cites this paper
• Aripiprazole in the Treatment of Depressive and Anxiety Disorders

  2008cites this paper
• Current and prospective pharmacological targets in relation to antimigraine action

  2008cites this paper
• 5-HT7 receptor-mediated dilatation in the middle meningeal artery of anesthetized rats.

  2007cites this paper
• Serotonin and Migraine: Biology and Clinical Implications

  2007cites this paper
• Cardiovascular responses produced by 5-hydroxytriptamine:a pharmacological update on the receptors/mechanisms involved and therapeutic implications

  2007cites this paper
• Clinical Evaluation of Melatonin Alone and in Combination with Pizotifen in the Prophylaxis of Migraine

  2007cites this paper
• ERGOT ALKALOIDS AND THEIR DERIVATIVES AS LIGANDS FOR SEROTONINERGIC , DOPAMINERGIC , AND ADRENERGIC RECEPTORS

  2006cites this paper
• Migraine: current concepts and emerging therapies.

  2005cites this paper
• Characterization of the 5-HT7receptor: Synthesis and molecular modeling of ligands and the receptor

  2005cites this paper
• Treatment of Refractory Chronic Daily Headache with the Atypical Antipsychotic Ziprasidone — A Case Series

  2005cites this paper
• CGRP Release and c-fos Expression within Trigeminal Nucleus Caudalis of the Rat following Glyceryltrinitrate Infusion

  2005cites this paper
• The role of nitric oxide in vascular headache

  2004cites this paper
• Nitroglycerin-Induced nNOS Increase in Rat Trigeminal Nucleus Caudalis is Inhibited by Systemic Administration of Lysine Acetylsalicylate but not of Sumatriptan

  2004cites this paper
• The emergence of selective 5-HT 2B antagonists structures, activities and potential therapeutic applications.

  2004cites this paper
• Functional 5-HT receptors in human occipital artery

  2004cites this paper
• In vitro pharmacological investigations of Sapindus trifoliatus in various migraine targets.

  2004cites this paper
• Influence of Serotonin on the Blood–Brain and the Blood–Spinal Cord Barriers

  2004cites this paper
• Genes and migraine.

  2004cites this paper
• Dilatation induced by 5-HT in the middle meningeal artery of the anaesthetised cat

  2004cites this paper
• Systemic administration of nitric oxide donor nitroglycerin as an experimental model for migraine headache in rats

  2004cites this paper
• ASSOCIATION ANALYSIS OF 5-HTTLPRVARIANTS, 5-HT2ARECEPTOR GENE 102T/CPOLYMORPHISM AND MIGRAINE

  2003cites this paper
• Neurogenic Dural Protein Extravasation Induced by Meta-Chlorophenylpiperazine (Mcpp) Involves Nitric Oxide and 5-HT2B Receptor Activation

  2003cites this paper
• An investigation of the 5‐HT2C receptor gene as a migraine candidate gene

  2003cites this paper
• Pharmacological analysis of red-wine-induced migrainous headaches

  2003cites this paper
• The role of nitric oxide in vascular headache

  2003cites this paper
• Despite the general correlation of the serotonin transporter gene regulatory region polymorphism (5-HTTLPR) and platelet serotonin concentration, lower platelet serotonin concentration in migraine patients is independent of the 5-HTTLPR variants.

  2003cites this paper
• Emerging drugs in migraine treatment

  2003cites this paper
• Therapeutic implications of central and peripheral neurologic mechanisms in migraine

  2003cites this paper
• Migraine: Preventive Treatment

  2002cites this paper
• THE CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES

  2002cites this paper
• Is the 5-HT(7) receptor involved in the pathogenesis and prophylactic treatment of migraine?

  2002influential citation
• Current experience with 5-HT3 receptor antagonists in fibromyalgia.

  2002cites this paper
• [Pathophysiology of migraine: models to explain the generation of migraine headache].

  2002cites this paper
• Biorhythms and possible central regulation of magnesium status, phototherapy, darkness therapy and chronopathological forms of magnesium depletion.

  2002cites this paper
• Insights into the structure and function of 5-HT2 familyserotonin receptors reveal novel strategies for therapeutic target development

  2001cites this paper
• Physiology of meningeal innervation: Aspects and consequences of chemosensitivity of meningeal nociceptors

  2001cites this paper
• Nitric oxide in primary headaches

  2001cites this paper
• Investigations into Migraine Pathogenesis: Time Course for Effects of m-CPP, BW723C86 or Glyceryl Trinitrate on Appearance of Fos-Like Immunoreactivity in Rat Trigeminal Nucleus Caudalis (TNC)

  2001cites this paper
• Sumatriptan elicits both constriction and dilation in human and bovine brain intracortical arterioles

  2001cites this paper
• Nitric oxide mechanisms in migraine.

  2000cites this paper
• [The physiopathology of migraine].

  2000cites this paper
• The serotonergic agent m-chlorophenylpiperazine induces migraine attacks: A controlled study

  2000cites this paper
• [The role of serotonin and serotonin receptors in the pathogenesis of migraine and in the mechanisms of action of anti-migraine drugs].

  2000cites this paper
• Nitric Oxide, Perivascular Neural Transmission, and Migraine

  2000cites this paper
• Role of nitric oxide in cluster headache

  1999cites this paper
• Pharmacological evidence for the 5‐HT7 receptor mediating smooth muscle relaxation in canine cerebral arteries

  1999cites this paper
• The induction of pain: an integrative review.

  1999cites this paper
• Involvement of the 5-HT7 receptor in craniovascular vasodilatation: potential impact in migraine.

  1998cites this paper
• Nitric oxide theory of migraine.

  1998cites this paper
• Comprehensive management of headache and depression.

  1998cites this paper
• Methysergide

  1998cites this paper
• 5‐HT1B receptor‐mediated contractions in human temporal artery: evidence from selective antagonists and 5‐HT receptor mRNA expression

  1998cites this paper
• Behavioral, physiological and neuroendocrine responses in healthy volunteers to m-chlorophenylpiperazine (m-CPP) with and without ondansetron pretreatment

  1997cites this paper
• A Pivotal Role of Nitric Oxide in Migraine Pain

  1997cites this paper
• Headache Induced by Serotonergic Agonists—a Key to the Interpretation of Migraine Pathogenesis?

  1997cites this paper
• Serotonergic effects of dotarizine in coronary artery and in oocytes expressing 5-HT2 receptors.

  1997cites this paper
• How do the Currently Used Prophylactic Agents Work in Migraine?

  1997cites this paper
• The M-Chlorophenylpiperazine Test in Cluster Headache

  1997cites this paper
• Investigations Into the Role of Nitric Oxide and the Large Intracranial Arteries in Migraine Headache

  1997cites this paper
• Pearls, pitfalls, and updates for pain management.

  1997cites this paper
• [Chronic pain treatment with antidepressants--metaanalysis].

  1997cites this paper
• Immunohistochemical localisation of the serotonin 5‐HT2B receptor in mouse gut, cardiovascular system, and brain

  1996cites this paper
• Novel discriminatory ligands for 5-HT2B receptors.

  1996cites this paper
• m-Chlorophenylpiperazine (mCPP) is an antagonist at the cloned human 5-HT2B receptor.

  1996cites this paper
• Endothelial 5‐HT receptors mediate relaxation of porcine pulmonary arteries in response to ergotamine and dihydroergotamine

  1996cites this paper
• Serotonin in the regulation of brain microcirculation.

  1996cites this paper
• Potent, selective tetrahydro-beta-carboline antagonists of the serotonin 2B (5HT2B) contractile receptor in the rat stomach fundus.

  1996cites this paper
• Activation of Meningeal 5‐HT2B Receptors: An Early Step in the Generation of Migraine Headache?

  1996cites this paper
• Participation of 5‐HT1‐like and 5‐HT2A receptors in the contraction of human temporal artery by 5‐hydroxytryptamine and related drugs

  1996cites this paper
• The autonomic nervous system and the regulation of arterial tone in migraine

  1995cites this paper
• Arterial mechanisms in the pathophysiology of migraine headache—implications for modern therapy

  1995cites this paper
• Is central hyperacusis a symptom of 5-hydroxytryptamine (5-HT) dysfunction?

  1995cites this paper
• The 5-hydroxytryptamine-nitric oxide connection: the key link in the initiation of migraine?

  1995cites this paper
• N-(1-methyl-5-indolyl)-N'-(3-methyl-5-isothiazolyl)urea: a novel, high-affinity 5-HT2B receptor antagonist.

  1995cites this paper
• The Nitric Oxide Hypothesis of Migraine and Other Vascular Headaches

  1995cites this paper